The importance of selection of evaluation indicators for antiviral therapy of chronic hepatitis B based on the clinical trial results of a CpAM

LI Gui-xin; LIU Hui; JIANG Qian-qian

doi:10.3969/j.issn.1674-3806.2021.12.02

Home>Articles>The importance of selection of evaluation indicators for antiviral therapy of chronic hepatitis B based on the clinical trial results of a CpAM

DOI: 10.3969/j.issn.1674-3806.2021.12.02

The importance of selection of evaluation indicators for antiviral therapy of chronic hepatitis B based on the clinical trial results of a CpAM

LI Gui-xin

LIU Hui

JIANG Qian-qian

Machine-generated Keywords：

Publication Date：2021-12-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 1163-1168 )

Chinese Journal of New Clinical Medicine

ISSN：1674-3806

Year, Vol.(Issue)：2021,14(12)